181 related articles for article (PubMed ID: 35925392)
1. Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure.
Greulich S; Mahrholdt H; Casadonte R; Steinmüller-Magin L; Latus J; Blessing F; Kriegsmann J; Bekeredjian R; Gawaz M; Klingel K
Clin Res Cardiol; 2023 Mar; 112(3):444-449. PubMed ID: 35925392
[No Abstract] [Full Text] [Related]
2. Transthyretin amyloid cardiomyopathy.
Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
[TBL] [Abstract][Full Text] [Related]
3. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.
Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J
BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin Cardiac Amyloidosis: From Rare Monogenic Disease to Common Pathway in Heart Failure?
Culotta V; Moon JC
Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):888-889. PubMed ID: 27514622
[No Abstract] [Full Text] [Related]
5. Understanding Changes in Functional Capacity After TTR Stabilization in Patients With Transthyretin Cardiac Amyloidosis.
Cuddy SAM
Circ Heart Fail; 2022 Jul; 15(7):e009387. PubMed ID: 35766044
[No Abstract] [Full Text] [Related]
6. Machine Learning Identifies Plasma Metabolites Associated With Heart Failure in Underrepresented Populations With the
Park JK; Petrazzini BO; Saha A; Vaid A; Vy HMT; Márquez-Luna C; Chan L; Nadkarni GN; Do R
J Am Heart Assoc; 2023 Apr; 12(8):e027736. PubMed ID: 37042260
[No Abstract] [Full Text] [Related]
7. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
8. Recognition and Implications of Undiagnosed Cardiac Amyloid Patients in HFpEF Trials.
Cheng RK; Maurer MS
JACC Heart Fail; 2021 Nov; 9(11):803-806. PubMed ID: 34509407
[No Abstract] [Full Text] [Related]
9. How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.
Izumiya Y; Hayashi H; Ishikawa H; Shibata A; Yoshiyama M
Intern Med; 2021 Jan; 60(1):1-7. PubMed ID: 32713926
[TBL] [Abstract][Full Text] [Related]
10. A review of transthyretin cardiac amyloidosis.
Jhawar N; Moreno JCL; Chirila R
Rom J Intern Med; 2023 Mar; 61(1):28-34. PubMed ID: 36278951
[TBL] [Abstract][Full Text] [Related]
11. Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy.
Rowin EJ; Ruberg FL; Das G; Higgins D; Lipe WC; Bokhari N; Dehn M; Maron BJ; Maron MS
Circ Cardiovasc Imaging; 2022 Dec; 15(12):e014938. PubMed ID: 36448453
[No Abstract] [Full Text] [Related]
12. Understanding and recognizing cardiac amyloidosis.
McVeigh T; Tennyson C
JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S
Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482
[TBL] [Abstract][Full Text] [Related]
14. Serial
Okada A; Tateishi E; Morita Y; Ohta-Ogo K; Izumi C
Circ Heart Fail; 2023 Jan; 16(1):e009595. PubMed ID: 36541213
[No Abstract] [Full Text] [Related]
15. Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin gene.
Damy T; Plante-Bordeneuve V; Valleix S
Arch Cardiovasc Dis; 2012 Nov; 105(11):614-5. PubMed ID: 23177490
[No Abstract] [Full Text] [Related]
16. Black Women and Transthyretin Amyloidosis: Insights From the Women's Health Initiative.
Falk RH; Kattan CG
JACC Heart Fail; 2023 Sep; 11(9):1200-1202. PubMed ID: 37354147
[No Abstract] [Full Text] [Related]
17. Acute cardiac failure secondary to senile systemic amyloidosis.
Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
[TBL] [Abstract][Full Text] [Related]
18. Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical Activity.
Lee YZJ; Fajardo J; Brown E; D'Adamo CR; Judge DP
J Cardiovasc Transl Res; 2022 Aug; 15(4):689-691. PubMed ID: 35083733
[No Abstract] [Full Text] [Related]
19. [Cardiac amyloidosis : simplifying the diagnosis of a complex disease].
Dayer N; Monney P; Hugelshofer S
Rev Med Suisse; 2024 May; 20(875):1010-1017. PubMed ID: 38783670
[TBL] [Abstract][Full Text] [Related]
20. A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.
Huda A; Castaño A; Niyogi A; Schumacher J; Stewart M; Bruno M; Hu M; Ahmad FS; Deo RC; Shah SJ
Nat Commun; 2021 May; 12(1):2725. PubMed ID: 33976166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
